Isotopia Molecular Imaging ltd

Prostate cancer continues to challenge clinicians worldwide, especially when it comes to achieving complete tumor removal. A new scientific review showcases 99mTc-PSMA Radioguided Surgery (RGS) as a promising innovation poised to reshape surgical standards. By selectively targeting #PSMA—commonly overexpressed in prostate cancer cells—surgeons can guide their operations using intraoperative gamma probes, detecting and excising even small lesions often missed by standard imaging. The key advantage: #99mTc tracers are both affordable and globally accessible, making them compatible with existing nuclear medicine infrastructure and scalable for hospitals everywhere. While clinical use of 99mTc-PSMA RGS is still in the investigative phase, emerging studies report improved surgical precision, improved PSA response rates, and, for certain patients, prolonged time before further treatment is needed. With continued validation, this technology can potentially bridge global gaps in prostate cancer treatment and redefine surgical success. 📖 Read the full article to explore the scientific and clinical insights by Haim Golan MD MSc: https://lnkd.in/dftDcr72 #Oncology #Urology #NuclearMedicine #Innovation #ProstateCancer #SurgicalOncology #MedicalTechnology #99mTc #PSMA

October marks Breast Cancer Awareness Month. The statistics remind us: 1 in 8 women will face breast cancer in their lifetime, and every two minutes, someone is diagnosed with this disease in the United States alone. But there is hope! When breast cancer is detected early, the chances of successful treatment are the highest—survival rates can reach 99% when detected at the localized stage. Everyone deserves the possibility of a superior outcome. Please remember to schedule a doctor’s appointment, pay attention to any changes in your body, and encourage your loved ones to do the same. Let’s spread knowledge, encourage early detection, and stand together with those who are coping breast cancer. #BreastCancerAwareness #EarlyDetection

The future of theranostics is here with Terbium-161. At EANM 2025, Isotopia will present Tb-161, a breakthrough isotope combining beta particles and Auger electrons for dual-action precision. Tb-161 targets cancer cells down to the single-cell level, including micrometastases, while sparing healthy tissue—thereby pushing nuclear medicine into a new era. With our vast expertise and incomparable infrastructure, we’re committed to advancing innovative solutions in nuclear medicine—today and for the future. 🤝 Schedule a meeting with our team https://lnkd.in/dXBdAsX7 📍 Booth #73C Come Say Hi :) @European Association of Nuclear Medicine (EANM) #EANM2025 #EANM #177Lu #Lutetium177 #Lutetium #PSMA #PSMA-11 #Gallium68 #Terbium #Terbium166 #Tb166 #radiopharmaceuticals #nuclearmedicine #molecularimaging #radionuclidetherapy #radiationtherapy #oncologytrials #theranostics #pharmaceutical #cancertreatment #prostatecancer #pharmaindustry #clinicaltrials #GMP #radioisotopes

As Prostate Cancer Awareness Month ends, Isotopia is honored to share a remarkable story, a patient’s life renewed through Lutetium-177 therapy, made possible by our partnership with the Oncidium foundation. This meaningful collaboration highlights our commitment to expanding access to innovative radiopharmaceutical treatments and offering hope to men with advanced prostate cancer. Throughout September, we have focused on education, patient support, and the life-changing role of nuclear medicine. Together, we are working toward brighter tomorrows, giving patients and families real hope in their journey against prostate cancer. #ProstateCancerAwareness #MensHealth #EarlyDetection

Meet Uria! ☺️  The man who keeps radioactive supplies running smoothly at Isotopia. He’s also a dreamer—whether it’s writing the next big TV hit, exploring the ocean, or crafting with wood, Uria proves there’s more than one way to tell a great story. Uria Goobi   #MeetTheTeam #TeamIsotopia #OurTeam

We’re expanding! Our aseptic manufacturing plant is relocating to a cutting-edge facility in Modiin, Israel. What’s New? ✅ 2,000+ m² advanced #pharma space 🔬 Industry-leading filling line & #isolator systems 🎖️ #GMP & #FDA compliance planned 🚅 Boosted capacity and speed for #radiopharmaceuticals Why Modiin? 🌏 Strategic location 🏢 Modern infrastructure 🎍 Business-friendly ecosystem 🤝 Ready for collaboration! Partner with Isotopia and access world-class aseptic manufacturing solutions tailored to every stage of your product’s journey – from clinical trials to commercial production. Connect with us today to accelerate innovation and advance precision medicine together. Read the full article: https://lnkd.in/dkQ4wsfV #NuclearMedicine #AsepticManufacturing #Innovation #pharmaindustry #HealthcareLeadership #clinicaltrials #lyophilization #SterilityStandards

Meet us at EANM 2025 in Barcelona and discover Isoprotrace® – our state-of-the-art PSMA-11 radiolabeling kit. With just 5-minute preparation, multiple doses per kit, and EU GMP / US FDA-approved facilities, Isoprotrace® is transforming prostate cancer diagnosis and staging. Now with marketing authorization in the Netherlands, UK, Germany, Sweden, Denmark, Malta, Cyprus, Greece and soon all across Europe! We’re setting new standards in precision imaging! 🤝 Schedule a meeting with our team https://lnkd.in/eVq2TnpG 📍 Booth #73C Come Say Hi :) European Association of Nuclear Medicine (EANM) #EANM2025 #EANM #177Lu #Lutetium177 #Lutetium #PSMA #PSMA-11 #Gallium68 #Terbium #Terbium166 #Tb166 #radiopharmaceuticals #nuclearmedicine #molecularimaging #radionuclidetherapy #radiationtherapy #oncologytrials #theranostics #pharmaceutical #cancertreatment #prostatecancer #pharmaindustry #clinicaltrials #GMP #radioisotopes

As Rosh Hashanah approaches, we find ourselves pausing to appreciate what truly matters — the people around us. 🙏 To our devoted team: thank you for your care, dedication, and the spirit you bring to our work every day. 🙏 To our partners: we’re grateful for the trust and the journey we share. 🙏 And to our patients: you inspire us to push further, to care deeper, and to never stop searching for new solutions. Alongside our wishes for a sweet new year, our hearts and thoughts are with our brothers and our sister still in captivity. We eagerly await your safe and swift return home. 🌸 May the new year bring us all health, hope, renewed connections, and moments of peace and happiness. Wishing you a #ShanaTova, from all of us at Isotopia.

Prostate cancer remains one of the most common cancers in men, and achieving complete tumor removal remains a major challenge. A new scientific review highlights 99mTc-PSMA Radioguided Surgery (RGS) as a promising innovation that may transform future outcomes. By targeting #PSMA—overexpressed in prostate cancer cells—surgeons can use intraoperative gamma probes to detect and remove even tiny lesions often missed by standard imaging. Unlike PET tracers, 99mTc is affordable, globally accessible, and compatible with existing nuclear medicine infrastructure, offering a scalable solution worldwide. While still experimental, early studies show improved precision, PSA response, and extended treatment-free survival. If validated, 99mTc-PSMA RGS could significantly reduce disparities in care and redefine prostate cancer surgery. 📖 Read the full article to explore the scientific and clinical insights by Haim Golan MD MSc: https://lnkd.in/dbHz_C5w #Oncology #Urology #NuclearMedicine #Innovation #ProstateCancer #SurgicalOncology #MedicalTechnology #99mTc #PSMA

At the European Association of Nuclear Medicine (EANM) 2025, we’re shining the spotlight on Lutetium-177 (n.c.a & c.a.) ✨ Backed by two additional production sites at Seibersdorf Laboratories in Europe and Isotopia USA, we provide a reliable, consistent, and sustainable supply of Lutetium-177 every week! Our mission is simple but vital: minimize risk, ensure continuity, and deliver life-extending treatments on time, everywhere. 🤝 Schedule a meeting with our team https://lnkd.in/dcrhJhgX 📍 Booth #73C Come Say Hi :) @European Association of Nuclear Medicine (EANM) #EANM2025 #EANM #177Lu #Lutetium177 #Lutetium #PSMA #PSMA-11 #Gallium68 #Terbium #Terbium166 #Tb166 #radiopharmaceuticals #nuclearmedicine #molecularimaging #radionuclidetherapy #radiationtherapy #oncologytrials #theranostics #pharmaceutical #cancertreatment #prostatecancer #pharmaindustry #clinicaltrials #GMP #radioisotopes